<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01956162</url>
  </required_header>
  <id_info>
    <org_study_id>PROT-ORTHO-0913</org_study_id>
    <nct_id>NCT01956162</nct_id>
  </id_info>
  <brief_title>Evaluation of a New Device &quot;Orthèse Diabète&quot; in the Healing of Foot Ulcers in Diabetic Patients</brief_title>
  <acronym>ORTHODIAB</acronym>
  <official_title>Evaluation of a New Customized Removable Device With Rocker Sole for Plantar Off-Loading &quot;Orthèse Diabète&quot; in the Healing of Foot Ulcers in Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Proteor Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société Francophone du Diabète</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Proteor Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center trial, randomized in 2 parallel groups, open label, with a blinded adjudication
      committee (PROBE methodology), comparing &quot;Orthèse Diabète&quot; with &quot;conventional&quot; removable
      devices in terms of healing of ulcers.

      - Primary objective: Evaluate the efficiency of &quot;Orthèse Diabète&quot; compared to &quot;conventional&quot;
      removable devices, in terms of the proportion of diabetic patients whose principal ulcer will
      heal completely at 3 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Secondary objectives

             1. Proportion of patients whose principal ulcer will heal completely at 1, 2 and 6
                months

             2. Proportion of patients in whom all initial plantar ulcers will heal completely at
                1, 2, 3 and 6 months

             3. Percentage of area decrease of the plantar ulcers at 1, 2, 3 and 6 months

             4. Time to healing of the principal ulcer

             5. Appearance of new ulcers

             6. Requirement for amputation

             7. Incidence of the infectious complications

             8. Adherence of wearing

             9. Patient's satisfaction with the prescribed device

        2. Population

             1. 13 centers/116 patients monitored for a period of 6 months maximum

             2. Experimental Group: &quot;Orthèse Diabète&quot; a plantar off-loading custom-made removable
                device

             3. Control group: &quot;Conventional&quot; removable off-loading systems among the devices
                available in France.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the efficiency of &quot;Orthèse Diabète&quot; compared to &quot;conventional&quot; removable devices, in terms of the proportion of diabetic patients whose principal ulcer will heal completely.</measure>
    <time_frame>At 3 months</time_frame>
    <description>Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients whose principal plantar ulcer will be fully healed</measure>
    <time_frame>At 1, 2 and 6 months</time_frame>
    <description>Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients whose all initial plantar ulcers will be fully healed.</measure>
    <time_frame>At 1, 2, 3 and 6 months</time_frame>
    <description>Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage decrease of the ulcer area</measure>
    <time_frame>At 1, 2, 3 and 6 months</time_frame>
    <description>The area is evaluated by the last measurement undertaken during the trial or prior to a serious event (death, amputation, orthopedic or vascular surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to healing of the principal ulcer</measure>
    <time_frame>From the patient's off-loading device delivery visit to the date of healing validated by the adjudication committee</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appearance of new ulcers on the affected foot and/or contralateral</measure>
    <time_frame>6 months</time_frame>
    <description>The following elements will be specified: cause, side, location, severity, treatment used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirement for amputation</measure>
    <time_frame>6 months</time_frame>
    <description>The following elements will be specified: date, side and level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of infectious complications</measure>
    <time_frame>6 months</time_frame>
    <description>This covers cutaneous infections (abscess and lymphangitis, erysipelas, hypodermitis, necrotizing fasciitis, gas gangrene), bone infections (osteitis, arthritis, osteoarthritis) or systemic infections requiring antibiotic therapy (oral or parenteral) or surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observance of the equipment</measure>
    <time_frame>6 months</time_frame>
    <description>Daily wear will be evaluated in the 2 groups through a semi-quantitative questionnaire provided to the patient at every visit. This evaluation will be supplemented with readings of the thermal sensor in the &quot;Orthèse Diabète &quot; group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients satisfaction with the prescribed device</measure>
    <time_frame>At 3 months</time_frame>
    <description>Evaluated with the &quot;QUEST ESAT&quot; questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>Foot Ulcer, Diabetic</condition>
  <arm_group>
    <arm_group_label>Group &quot;Orthèse Diabète&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using &quot;Orthèse Diabète&quot;, a new customized removable device with rocker sole for plantar off-loading</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using &quot;Conventional devices&quot;, removable off-loading systems among the devices available in France</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orthèse Diabète</intervention_name>
    <description>The device ensures the discharge of the wound by the excavation of the orthopedic insole facing the wound and the load distribution in the healthy areas.</description>
    <arm_group_label>Group &quot;Orthèse Diabète&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>&quot;Conventional&quot; Device</intervention_name>
    <description>Standard (e.g.: CHUT, BAROUK, Tera-Diab, Sanital, Teraheel, Aircast boots, Walker Stabil D, etc.), or customized (orthopedic insole, Ransart boot, D.T.A.C.P., etc.) removable off-loading systems</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 or type 2 diabetic patients diagnosed according to the ADA experts consensus
             [ADA 1997]

          -  Over 18 years of age

          -  With a sensory neuropathy (abnormal 10 g monofilament test, i.e. not perceived at
             least 2 times in 1 of the 3 areas explored : pulp of the great toe, 1st and 5th
             metatarsal heads)

          -  Without a severe arteriopathy defined by : ABI &lt; 0,7 and/or TcPO2 &lt; 30 mm Hg and/or
             big toe pressure &lt; 30 mm Hg

          -  with one or more plantar ulcerations with an area &gt; 0,25 cm² or an amputation (toes or
             transmetatarsal) open or sutured

          -  not requiring a contralateral off-loading device

          -  Informed about the study and having given their informed and written consent to
             participate

          -  registered with a social security scheme or with the CMU (beneficiary or entitled
             recipient)

          -  having undergone a medical exam

          -  not included in another protocol throughout the study

        Exclusion Criteria:

          -  Severe skin or osteoarticular infection requiring a parenteral antibiotic therapy or
             surgery

          -  Large ulcer of the ipsilateral leg &gt; 20 cm2 of area

          -  Contralateral above heel amputation

          -  Intercurrent disease prohibiting participation in the protocol

          -  Weight over 130 Kg

          -  Person under tutorship or under curatorship

          -  Loss of functional and/or neuropsychological autonomy

          -  Pregnant or likely to be pregnant woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kamel Mohammedi, Diabetology</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bichat Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bichat Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75877</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.sfdiabete.org/</url>
    <description>Francophone Diabetes Society Website</description>
  </link>
  <reference>
    <citation>Malgrange D. [Physiopathology of the diabetic foot]. Rev Med Interne. 2008 Sep;29 Suppl 2:S231-7. doi: 10.1016/S0248-8663(08)73950-X. Review. French.</citation>
    <PMID>18822248</PMID>
  </reference>
  <reference>
    <citation>Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet. 2005 Nov 12;366(9498):1725-35. Review.</citation>
    <PMID>16291067</PMID>
  </reference>
  <reference>
    <citation>Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999 Mar;22(3):382-7.</citation>
    <PMID>10097914</PMID>
  </reference>
  <reference>
    <citation>Muller IS, de Grauw WJ, van Gerwen WH, Bartelink ML, van Den Hoogen HJ, Rutten GE. Foot ulceration and lower limb amputation in type 2 diabetic patients in dutch primary health care. Diabetes Care. 2002 Mar;25(3):570-4.</citation>
    <PMID>11874949</PMID>
  </reference>
  <reference>
    <citation>Detournay B, Cros S, Charbonnel B, Grimaldi A, Liard F, Cogneau J, Fagnani F, Eschwège E. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab. 2000 Nov;26(5):363-9.</citation>
    <PMID>11119015</PMID>
  </reference>
  <reference>
    <citation>Detournay B, Raccah D, Cadilhac M, Eschwège E. Epidemiology and costs of diabetes treated with insulin in France. Diabetes Metab. 2005 Jun;31(3 Pt 2):3-18.</citation>
    <PMID>16142041</PMID>
  </reference>
  <reference>
    <citation>Malgrange D, Richard JL, Leymarie F; French Working Group On The Diabetic Foot. Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France. Diabetes Metab. 2003 Jun;29(3):261-8.</citation>
    <PMID>12909814</PMID>
  </reference>
  <reference>
    <citation>Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993 Jun;233(6):485-91.</citation>
    <PMID>8501419</PMID>
  </reference>
  <reference>
    <citation>Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005 Nov 12;366(9498):1719-24. Review.</citation>
    <PMID>16291066</PMID>
  </reference>
  <reference>
    <citation>Moxey PW, Hofman D, Hinchliffe RJ, Jones K, Thompson MM, Holt PJ. Epidemiological study of lower limb amputation in England between 2003 and 2008. Br J Surg. 2010 Sep;97(9):1348-53. doi: 10.1002/bjs.7092.</citation>
    <PMID>20632310</PMID>
  </reference>
  <reference>
    <citation>Resnick HE, Carter EA, Sosenko JM, Henly SJ, Fabsitz RR, Ness FK, Welty TK, Lee ET, Howard BV; Strong Heart Study. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. 2004 Aug;27(8):1885-91.</citation>
    <PMID>15277412</PMID>
  </reference>
  <reference>
    <citation>Fosse S, Hartemann-Heurtier A, Jacqueminet S, Ha Van G, Grimaldi A, Fagot-Campagna A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med. 2009 Apr;26(4):391-6. doi: 10.1111/j.1464-5491.2009.02698.x.</citation>
    <PMID>19388969</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2013</study_first_submitted>
  <study_first_submitted_qc>October 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2013</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

